BioCorRx (BICX) Research & Development (2017 - 2026)
BioCorRx recorded quarterly Research & Development of $352333.0 in Q1 2026, down 80.08% quarter-over-quarter from $1.8 million in Q4 2025, and up 117.6% year-over-year from $161919.0 in Q1 2025.
BioCorRx's Research & Development history runs 10 years deep, the most recent figure standing at $352333.0 for Q1 2026.
- In Q1 2026, Research & Development rose 117.6% year-over-year to $352333.0; the TTM figure through Mar 2026 stood at $3.4 million (up 139.2% YoY), while the FY2025 annual figure was $1.8 million, up 19.29% from the prior year.
- Research & Development came in at $352333.0 for Q1 2026 at BioCorRx, down from $1.8 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.8 million in Q4 2025 to a low of $128295.0 in Q4 2023.
- A 5-year average of $436360.3 and a median of $296860.0 in 2025 frame the typical range for Research & Development.
- Across the five-year window, Research & Development sank 76.07% in 2023 and soared 549.06% in 2025, its largest moves.
- BioCorRx's Research & Development stood at $536104.0 in 2022, then tumbled by 76.07% to $128295.0 in 2023, then jumped by 112.43% to $272543.0 in 2024, then jumped by 549.06% to $1.8 million in 2025, then tumbled by 80.08% to $352333.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $352333.0, $1.8 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | - |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | - |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | - |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | - |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 45.40 Mn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | - |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | - |
| 10 | BioCorRx | - | - | 189,355.00 | 352,333.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 352,333.00 |
| Dec 31, 2025 | 305,516.00 |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 296,860.00 |
| Mar 31, 2025 | 161,919.00 |
| Dec 31, 2024 | 272,543.00 |
| Sep 30, 2024 | 460,138.00 |
| Jun 30, 2024 | 536,362.00 |
| Mar 31, 2024 | 213,834.00 |
| Dec 31, 2023 | 128,295.00 |
| Sep 30, 2023 | 286,962.00 |
| Jun 30, 2023 | 238,419.00 |
| Mar 31, 2023 | 237,387.00 |
| Dec 31, 2022 | 536,104.00 |
| Sep 30, 2022 | 342,553.00 |
| Jun 30, 2022 | 382,952.00 |
| Mar 31, 2022 | 197,849.00 |
| Dec 31, 2021 | 234,423.00 |
| Sep 30, 2021 | 589,985.00 |
| Jun 30, 2021 | 123,262.00 |
| Mar 31, 2021 | 658,237.00 |
| Dec 31, 2020 | 928,845.00 |
| Sep 30, 2020 | 1.29 Mn |
| Jun 30, 2020 | 1.35 Mn |
| Mar 31, 2020 | 710,570.00 |
| Dec 31, 2019 | 545,732.00 |
| Sep 30, 2019 | 298,263.00 |
| Jun 30, 2019 | 135,138.00 |
| Mar 31, 2019 | 145,965.00 |
| Dec 31, 2018 | 57,003.00 |
| Sep 30, 2018 | 35,759.00 |
| Mar 31, 2018 | 59,006.00 |
| Dec 31, 2017 | 291,692.00 |
| Sep 30, 2017 | 107,460.00 |
| Jun 30, 2017 | 43,339.00 |
| Mar 31, 2017 | 8,231.00 |